![Erick Gamelin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erick Gamelin
Corporate Officer/Principal bij
ACRIVON THERAPEUTICS, INC.
Vermogen: 84 787 $ op 31-05-2026
Profiel
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 52.992 ( 0,12% ) | 84 787 $ | 31-05-2026 |
Actieve functies van Erick Gamelin
| Bedrijven | Functie | Begin |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 03-01-2024 |
Eerdere bekende functies van Erick Gamelin
| Bedrijven | Functie | Einde |
|---|---|---|
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01-10-2019 |
| MACROGENICS, INC. | Corporate Officer/Principal | 01-03-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
